[在血小板减少的情况下胸腔穿刺:现行指南]。

Q4 Medicine
Celia Mach, Pauline Darbellay Farhoumand
{"title":"[在血小板减少的情况下胸腔穿刺:现行指南]。","authors":"Celia Mach, Pauline Darbellay Farhoumand","doi":"10.53738/REVMED.2025.21.934.47738","DOIUrl":null,"url":null,"abstract":"<p><p>Thoracentesis, even in patients with significant thrombocytopenia, carries a very low risk of major bleeding when performed under ultrasound guidance. Based on observational studies, current guidelines challenge the need for routine coagulation testing or prophylactic platelet transfusion. Low-quality and mainly indirect evidence suggests the safety of a platelet threshold above 20 × 109/l. Avoiding thoracentesis based solely on laboratory values may delay diagnosis, prompt more invasive procedures, and increase complication risk. Clinical decision-making should be guided by an individualized risk-benefit assessment rather than fixed laboratory thresholds.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 934","pages":"1801-1802"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Thoracentesis in the setting of thrombocytopenia : current guidelines].\",\"authors\":\"Celia Mach, Pauline Darbellay Farhoumand\",\"doi\":\"10.53738/REVMED.2025.21.934.47738\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Thoracentesis, even in patients with significant thrombocytopenia, carries a very low risk of major bleeding when performed under ultrasound guidance. Based on observational studies, current guidelines challenge the need for routine coagulation testing or prophylactic platelet transfusion. Low-quality and mainly indirect evidence suggests the safety of a platelet threshold above 20 × 109/l. Avoiding thoracentesis based solely on laboratory values may delay diagnosis, prompt more invasive procedures, and increase complication risk. Clinical decision-making should be guided by an individualized risk-benefit assessment rather than fixed laboratory thresholds.</p>\",\"PeriodicalId\":21286,\"journal\":{\"name\":\"Revue medicale suisse\",\"volume\":\"21 934\",\"pages\":\"1801-1802\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue medicale suisse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53738/REVMED.2025.21.934.47738\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.934.47738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

在超声引导下进行胸腔穿刺时,即使是有明显血小板减少症的患者,发生大出血的风险也很低。根据观察性研究,目前的指南对常规凝血试验或预防性血小板输注的必要性提出了质疑。低质量且主要是间接的证据表明,血小板阈值高于20 × 109/l是安全的。仅根据实验室检查结果避免胸腔穿刺可能会延误诊断,促使进行更具侵入性的手术,并增加并发症的风险。临床决策应以个体化的风险-收益评估为指导,而不是固定的实验室阈值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Thoracentesis in the setting of thrombocytopenia : current guidelines].

Thoracentesis, even in patients with significant thrombocytopenia, carries a very low risk of major bleeding when performed under ultrasound guidance. Based on observational studies, current guidelines challenge the need for routine coagulation testing or prophylactic platelet transfusion. Low-quality and mainly indirect evidence suggests the safety of a platelet threshold above 20 × 109/l. Avoiding thoracentesis based solely on laboratory values may delay diagnosis, prompt more invasive procedures, and increase complication risk. Clinical decision-making should be guided by an individualized risk-benefit assessment rather than fixed laboratory thresholds.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revue medicale suisse
Revue medicale suisse Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
1210
期刊介绍: Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信